Hospital and outpatient health services utilization among HIV-infected patients in care in 1999

Lawrence Crane, Robb Crowe, Steven Fine, Marla Gold, Kathye Gorosh, Marc Gourevitch, James Hellinger, John Jovanovich, Gary Kalkut, Philip Keiser, Chris Matthews, Jeffrey Nadler, Patrick Nemechek, John Post, Bruce Goldberg, Richard Rutstein, Victoria Sharp, Fred Hellinger, John Fleishman, Irene Frazer & 8 others Richard Conviser, Joan Dilonardo, Paul Gaist, Richard Moore, Jeanne Keruly, Kelly Gebo, Erin Reilly, Ming Zhao

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Background: The evolving epidemiology and therapeutic management of HIV disease has important implications for health care resource utilization in HIV-infected patients, and health care resource use data are also needed to support policy and financial decision making. Methods: Demographic, clinical, and resource utilization data were collected from 9 U.S. HIV primary and specialty care sites in calendar year 1999. Rates of resource use were calculated for hospital admission, length of hospital stay, and outpatient clinic/office visits. Results: The sample included 5255 patients from HIV primary care sites in 3 eastern, 3 midwestern, and 3 western areas of the United States. Hospital admissions accounted for an annual mean of 297 days per 100 persons/y in 1999. Hospital days ranged from a low of 165 per 100 persons/mo for a CD4 > 500 cells/mm3 to 840 per 100 persons/mo for a CD4 < 50 cells/mm3 (p < .01). Mean annual outpatient clinic/office visits were 10.7 per person in 1999. A declining CD4 level and an increasing HIV-1 RNA level were both associated with higher hospital and outpatient utilization. HAART use was associated with fewer hospital days, and a higher outpatient visit rate. Injecting drug use risk was associated with an increase in hospital days. African American race was associated with a higher number of hospital days, but a lower outpatient visit rate. Female gender was associated with higher outpatient utilization. Mean monthly inpatient and outpatient expenditures in 1999 were $423 and $168, respectively. Conclusion: As HIV care continues to evolve, data from our network of HIV providers will be useful in quantifying changes in HIV health services utilization to guide policy makers, as well as HIV care payers and providers.

Original languageEnglish (US)
Pages (from-to)21-26
Number of pages6
JournalJournal of Acquired Immune Deficiency Syndromes
Volume30
Issue number1
DOIs
StatePublished - May 1 2002
Externally publishedYes

Fingerprint

Ambulatory Care
Patient Care
HIV
Outpatients
Office Visits
Health Resources
Length of Stay
Primary Health Care
Patient Acceptance of Health Care
Hospital Outpatient Clinics
Financial Support
Highly Active Antiretroviral Therapy
Disease Management
Health Expenditures
Ambulatory Care Facilities
Administrative Personnel
African Americans
Health Services
HIV-1
Inpatients

Keywords

  • Antiretroviral therapy
  • Cost of care
  • Health services
  • Hospital admission
  • Resource use

ASJC Scopus subject areas

  • Virology
  • Immunology

Cite this

Hospital and outpatient health services utilization among HIV-infected patients in care in 1999. / Crane, Lawrence; Crowe, Robb; Fine, Steven; Gold, Marla; Gorosh, Kathye; Gourevitch, Marc; Hellinger, James; Jovanovich, John; Kalkut, Gary; Keiser, Philip; Matthews, Chris; Nadler, Jeffrey; Nemechek, Patrick; Post, John; Goldberg, Bruce; Rutstein, Richard; Sharp, Victoria; Hellinger, Fred; Fleishman, John; Frazer, Irene; Conviser, Richard; Dilonardo, Joan; Gaist, Paul; Moore, Richard; Keruly, Jeanne; Gebo, Kelly; Reilly, Erin; Zhao, Ming.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 30, No. 1, 01.05.2002, p. 21-26.

Research output: Contribution to journalArticle

Crane, L, Crowe, R, Fine, S, Gold, M, Gorosh, K, Gourevitch, M, Hellinger, J, Jovanovich, J, Kalkut, G, Keiser, P, Matthews, C, Nadler, J, Nemechek, P, Post, J, Goldberg, B, Rutstein, R, Sharp, V, Hellinger, F, Fleishman, J, Frazer, I, Conviser, R, Dilonardo, J, Gaist, P, Moore, R, Keruly, J, Gebo, K, Reilly, E & Zhao, M 2002, 'Hospital and outpatient health services utilization among HIV-infected patients in care in 1999', Journal of Acquired Immune Deficiency Syndromes, vol. 30, no. 1, pp. 21-26. https://doi.org/10.1097/00126334-200205010-00003
Crane, Lawrence ; Crowe, Robb ; Fine, Steven ; Gold, Marla ; Gorosh, Kathye ; Gourevitch, Marc ; Hellinger, James ; Jovanovich, John ; Kalkut, Gary ; Keiser, Philip ; Matthews, Chris ; Nadler, Jeffrey ; Nemechek, Patrick ; Post, John ; Goldberg, Bruce ; Rutstein, Richard ; Sharp, Victoria ; Hellinger, Fred ; Fleishman, John ; Frazer, Irene ; Conviser, Richard ; Dilonardo, Joan ; Gaist, Paul ; Moore, Richard ; Keruly, Jeanne ; Gebo, Kelly ; Reilly, Erin ; Zhao, Ming. / Hospital and outpatient health services utilization among HIV-infected patients in care in 1999. In: Journal of Acquired Immune Deficiency Syndromes. 2002 ; Vol. 30, No. 1. pp. 21-26.
@article{b3c8ccc84c73497691ac76abe96bd99a,
title = "Hospital and outpatient health services utilization among HIV-infected patients in care in 1999",
abstract = "Background: The evolving epidemiology and therapeutic management of HIV disease has important implications for health care resource utilization in HIV-infected patients, and health care resource use data are also needed to support policy and financial decision making. Methods: Demographic, clinical, and resource utilization data were collected from 9 U.S. HIV primary and specialty care sites in calendar year 1999. Rates of resource use were calculated for hospital admission, length of hospital stay, and outpatient clinic/office visits. Results: The sample included 5255 patients from HIV primary care sites in 3 eastern, 3 midwestern, and 3 western areas of the United States. Hospital admissions accounted for an annual mean of 297 days per 100 persons/y in 1999. Hospital days ranged from a low of 165 per 100 persons/mo for a CD4 > 500 cells/mm3 to 840 per 100 persons/mo for a CD4 < 50 cells/mm3 (p < .01). Mean annual outpatient clinic/office visits were 10.7 per person in 1999. A declining CD4 level and an increasing HIV-1 RNA level were both associated with higher hospital and outpatient utilization. HAART use was associated with fewer hospital days, and a higher outpatient visit rate. Injecting drug use risk was associated with an increase in hospital days. African American race was associated with a higher number of hospital days, but a lower outpatient visit rate. Female gender was associated with higher outpatient utilization. Mean monthly inpatient and outpatient expenditures in 1999 were $423 and $168, respectively. Conclusion: As HIV care continues to evolve, data from our network of HIV providers will be useful in quantifying changes in HIV health services utilization to guide policy makers, as well as HIV care payers and providers.",
keywords = "Antiretroviral therapy, Cost of care, Health services, Hospital admission, Resource use",
author = "Lawrence Crane and Robb Crowe and Steven Fine and Marla Gold and Kathye Gorosh and Marc Gourevitch and James Hellinger and John Jovanovich and Gary Kalkut and Philip Keiser and Chris Matthews and Jeffrey Nadler and Patrick Nemechek and John Post and Bruce Goldberg and Richard Rutstein and Victoria Sharp and Fred Hellinger and John Fleishman and Irene Frazer and Richard Conviser and Joan Dilonardo and Paul Gaist and Richard Moore and Jeanne Keruly and Kelly Gebo and Erin Reilly and Ming Zhao",
year = "2002",
month = "5",
day = "1",
doi = "10.1097/00126334-200205010-00003",
language = "English (US)",
volume = "30",
pages = "21--26",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Hospital and outpatient health services utilization among HIV-infected patients in care in 1999

AU - Crane, Lawrence

AU - Crowe, Robb

AU - Fine, Steven

AU - Gold, Marla

AU - Gorosh, Kathye

AU - Gourevitch, Marc

AU - Hellinger, James

AU - Jovanovich, John

AU - Kalkut, Gary

AU - Keiser, Philip

AU - Matthews, Chris

AU - Nadler, Jeffrey

AU - Nemechek, Patrick

AU - Post, John

AU - Goldberg, Bruce

AU - Rutstein, Richard

AU - Sharp, Victoria

AU - Hellinger, Fred

AU - Fleishman, John

AU - Frazer, Irene

AU - Conviser, Richard

AU - Dilonardo, Joan

AU - Gaist, Paul

AU - Moore, Richard

AU - Keruly, Jeanne

AU - Gebo, Kelly

AU - Reilly, Erin

AU - Zhao, Ming

PY - 2002/5/1

Y1 - 2002/5/1

N2 - Background: The evolving epidemiology and therapeutic management of HIV disease has important implications for health care resource utilization in HIV-infected patients, and health care resource use data are also needed to support policy and financial decision making. Methods: Demographic, clinical, and resource utilization data were collected from 9 U.S. HIV primary and specialty care sites in calendar year 1999. Rates of resource use were calculated for hospital admission, length of hospital stay, and outpatient clinic/office visits. Results: The sample included 5255 patients from HIV primary care sites in 3 eastern, 3 midwestern, and 3 western areas of the United States. Hospital admissions accounted for an annual mean of 297 days per 100 persons/y in 1999. Hospital days ranged from a low of 165 per 100 persons/mo for a CD4 > 500 cells/mm3 to 840 per 100 persons/mo for a CD4 < 50 cells/mm3 (p < .01). Mean annual outpatient clinic/office visits were 10.7 per person in 1999. A declining CD4 level and an increasing HIV-1 RNA level were both associated with higher hospital and outpatient utilization. HAART use was associated with fewer hospital days, and a higher outpatient visit rate. Injecting drug use risk was associated with an increase in hospital days. African American race was associated with a higher number of hospital days, but a lower outpatient visit rate. Female gender was associated with higher outpatient utilization. Mean monthly inpatient and outpatient expenditures in 1999 were $423 and $168, respectively. Conclusion: As HIV care continues to evolve, data from our network of HIV providers will be useful in quantifying changes in HIV health services utilization to guide policy makers, as well as HIV care payers and providers.

AB - Background: The evolving epidemiology and therapeutic management of HIV disease has important implications for health care resource utilization in HIV-infected patients, and health care resource use data are also needed to support policy and financial decision making. Methods: Demographic, clinical, and resource utilization data were collected from 9 U.S. HIV primary and specialty care sites in calendar year 1999. Rates of resource use were calculated for hospital admission, length of hospital stay, and outpatient clinic/office visits. Results: The sample included 5255 patients from HIV primary care sites in 3 eastern, 3 midwestern, and 3 western areas of the United States. Hospital admissions accounted for an annual mean of 297 days per 100 persons/y in 1999. Hospital days ranged from a low of 165 per 100 persons/mo for a CD4 > 500 cells/mm3 to 840 per 100 persons/mo for a CD4 < 50 cells/mm3 (p < .01). Mean annual outpatient clinic/office visits were 10.7 per person in 1999. A declining CD4 level and an increasing HIV-1 RNA level were both associated with higher hospital and outpatient utilization. HAART use was associated with fewer hospital days, and a higher outpatient visit rate. Injecting drug use risk was associated with an increase in hospital days. African American race was associated with a higher number of hospital days, but a lower outpatient visit rate. Female gender was associated with higher outpatient utilization. Mean monthly inpatient and outpatient expenditures in 1999 were $423 and $168, respectively. Conclusion: As HIV care continues to evolve, data from our network of HIV providers will be useful in quantifying changes in HIV health services utilization to guide policy makers, as well as HIV care payers and providers.

KW - Antiretroviral therapy

KW - Cost of care

KW - Health services

KW - Hospital admission

KW - Resource use

UR - http://www.scopus.com/inward/record.url?scp=18344385139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18344385139&partnerID=8YFLogxK

U2 - 10.1097/00126334-200205010-00003

DO - 10.1097/00126334-200205010-00003

M3 - Article

VL - 30

SP - 21

EP - 26

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 1

ER -